Other granulomatous disorders of the skin and subcutaneous tissue
ICD-10 L92.8 is a billable code used to indicate a diagnosis of other granulomatous disorders of the skin and subcutaneous tissue.
L92.8 refers to other granulomatous disorders of the skin and subcutaneous tissue, which encompasses a variety of conditions characterized by the formation of granulomas. Granulomas are small areas of inflammation that occur when the immune system attempts to wall off substances it perceives as foreign but cannot eliminate. Clinically, patients may present with nodular lesions, erythema, and sometimes ulceration. Commonly affected areas include the face, trunk, and extremities. The disease progression can vary; some granulomatous disorders may resolve spontaneously, while others can persist or recur, leading to significant morbidity. Diagnostic considerations include a thorough clinical examination, patient history, and often a biopsy to confirm the presence of granulomas and rule out other conditions such as infections or malignancies. Laboratory tests may also be employed to identify underlying systemic diseases that could contribute to granuloma formation.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
L92.8 includes conditions such as necrobiosis lipoidica, granulomatous dermatitis, and other unspecified granulomatous skin disorders. Each condition has distinct clinical features and may require specific diagnostic criteria for accurate coding.
L92.8 should be used when the granulomatous disorder does not fit into more specific categories like sarcoidosis or granuloma annulare. It is essential to differentiate based on clinical presentation and histological findings.
Documentation should include a detailed patient history, clinical examination findings, and biopsy results confirming granuloma formation. Additional lab tests that rule out other conditions may also be necessary.
